CIRM Clinical Dashboard
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
| Disease Areas | Investigator | Organization | Phase |
Trial Status |
Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
| Ralph Kern | BrainStorm Cell Therapeutics | Phase 3 | Completed | 263 | ||
| Jane Lebkowski | Geron Corporation | Phase 1 | Completed | 5 | ||
| Vicki Wheelock | University of California, Davis | Phase 1/2 | Completed | 29 | ||
| Francois Binette | Lineage Cell Therapeutics Inc. | Phase 1/2 | Completed | 25 | ||
| Bijan Nejadnik | SanBio, Inc. | Phase 2 | Completed | 163 | ||
| Clive Svendsen | Cedars-Sinai Medical Center | Phase 1/2 | Completed | 18 | ||
| Clive Svendsen | Cedars-Sinai Medical Center | Phase 1 | Launching | N/A | ||
| Krystof Bankiewicz | Brain Neurotherapy Bio | Phase 1 | Recruiting | 12 | ||
|
Diana Farmer | University of California, Davis | Phase 1 | Recruiting | 55 | |
| Gary Steinberg | Stanford University | Phase 1 | Recruiting | 30 | ||
|
Cory Nicholas | Neurona Therapeutics | Phase 1 | Recruiting | 40 |
